| Group S (n = 33) | Group R (n = 34) | Group RA (n = 35) |
P value (overall) |
---|
Etsevo15 (Vol%) | 2.5 ± 0.1 | 2.1 ± 0.2*
| 2.2 ± 0.2*
| < 0.001 |
Etsevo30 (Vol%) | 2.4 ± 0.2 | 2.1 ± 0.2*
| 2.1 ± 0.2*
| < 0.001 |
Etsevo45 (Vol%) | 2.3 ± 0.2 | 2.0 ± 0.2*
| 2.0 ± 0.2*
| < 0.001 |
- Data presented as mean ± SD
- Group S, patients received sevoflurane; Group R, patients received sevoflurane and continuous infusion of remifentanil; Group RA, patients received sevoflurane, continuous infusion of remifentanil, and alfentanil given 10Â min before the end of surgery
-
Etsevo15, Etsevo30, Etsevo45 end-tidal sevoflurane concentration at 15Â min, 30Â min, and 45Â min after induction of anesthesia, respectively
-
*
P < 0.05 compared with group S